
Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a strategic review aimed at optimizing the portfolio.
Kirk Perry will be the interim chief executive as the company searches for a permanent replacement, it confirmed in a press release on July 14.